SEB Venture Capital an active partner

1
SEB Venture Capital - an active partner
2
SEB is a significant player in the private equity
market
SEB Private Equity EUR 1.1bn
SEB Enskilda
SEB Acquisition Finance EUR 1.5bn
SEB Venture Capital - EURM 270
KTH Chalmers Capital
Bank financing
Venture Capital
In addition, SEB is an investor in EQT,
Innovations Kapital, AskEmbla (Baltics) etc
3
SEB Venture Capital

• Our business concept
• We invest venture capital and supply expertise
  and a broad network of contacts to growth
  companies in the Technology, Life Science and
  Industrial Growth sectors

4
SEB Venture Capital in brief

• Evergreen fund structure 270 m
• No. of existing direct investments 36
• Technology 22
• Life Science 13
• Industrial Growth 1
• No. of existing fund investments 7
• No. of exits 40
• No. of professionals 20
• Established 1995

5
SEB Venture Capital in brief...

• Balanced portfolio vis-à-vis sector and maturity
• Significant minority owners
• Max. investment sum 10 m
• Investment horizon of up to 7 years
• Exit experience and focus

6
Investment criteria

• The company has a unique product or service with
  a sustainable competitive edge
• Highly skilled management who are also partners
  in the company
• Business concept with international market
  potential

7
Active ownership - value creation

• Powerful networks
• Experienced venture team
• Industry-specific expertise
• Close co-operation with management
• Commitment
• Board representation
• International presence

8
SEB Venture Capital - Organisation
SEB Venture Capital Ola Romney
Nordic Ola Romney
Baltic Ola Romney
U.K Nigel Pilkington
Stockholm
Vilnius
London
Gothenburg
Malmo
9
Professionals Nordic Team
Business DevelopmentHealth Care
Ola Romney Global Head of SEB Venture Capital
Arpinée Åhrberg Assistant
Viktor Drvota, MD, PhD
Investment Managers
Business Controller
Senior Investment Managers
Hans Engblom
Björn Österlund
Ulf Lewander
Anna Gustafsson
Andreas Pennervall
Venture Analyst
Jonas Nyman
Patrik Westerberg
Stefan Olofsson
Johan Wolf
Rickard Peterson
10
Professionals Baltic Team
Senior Investment Manager
Investment Manager
Andrejus Bojcovas
Danielis Klickmanas
Professionals U.K Team
Head of Venture Capital, London
Senior Investment Manager
Investment Manager
Venture Analyst
Nigel Pilkington
Frank Kelcz
James Raby
Richard Perlhagen
11
Co- investors
Industrifonden Industrivärden Innovationskapital
Investor Growth Capital Kantonal Bank Karolinska
Investment Fund KIHAB KTH Chalmers
Capital Latour LD Malmöhusinvest Metall Metallica
Microdrug Nordic BioScience Nordic Biotech Novo
AS Optiomi Pomona Schibstedt 6e
AP-Fonden SLS Skandia Skanditek Sunstone
Capital Teknoseed Universal W-Capital Wallgrund Ör
esund
3i ABN Amro Abingworth Applied Biosystems Alafi
Capital Aloe Private Equity Atlas
Ventures Bankinvest Beijer Biofund Bure CapMan Cen
trecourt Chalmersinvest Cimon Cirkus Concordia
Capital CRT Credit Suisse Dansk
Erhvervsinvestering Dansk Kapitalanlaeg Danish
Investment Fund EMA Emano Grimaldi
Industrier Företagsbyggarna GE Capital Healthcap H
B Capital IDI


12
Selected exits to date - Technology
Divestment of to Motorola Inc Amount not
disclosed 2006
Divestment of to Wind River For a value of
21.5m 2006
Divestment of
to the largest biodiesel producer in Baltic
States, to StatoilHydro 2007
13
Selected exits to date Life Science
Divestment of to Crucell N.V. for a min
value of 39.4 m 2006
Initial Public Offering of on the London
Stock Exchange / AIM 2006
Divestment of to Astra Tech Amount not
disclosed 2005
14
Portfolio companies
Newcastle
Cambridge
London
Umeå
Örnsköldsvik
Sundsvall
Uppsala
Norrtälje
Västerås
Stockholm
Linköping
Göteborg
Ängelholm
Malmö
Köpenhamn
Panevezys
Klaipeda
Vilnius
15
Portfolio companies - Technology

• A system for the manufacture of powerful, compact
  lasers in visible and infra-red wavelengths

• Platforms and products in telematics, e.g.
  elevator communication

• Develops and administers loyalty schemes within
  CRM

• A supplier of bio fuel heating plants and
  Combined Heat and Power (CHP) plants. KMW Energi
  supplies turn-key solutions, where the Company
  designs the entire combustion process.

16
Portfolio companies - Technology

• Software program for long-term planning and
  scheduling of personnel

• SP Devices develops and markets signal processing
  electronics and algorithms.

• Xylophane AB has developed a new barrier material
  for packaging. The material is based on
  natural raw material and is renewable and
  biodegradable

17
Portfolio companies - Technology

• KTH Chalmers Capital invests in early stage
  high-tech companies in conjunction with Research
  and Development at Royal Institute of Technology
  (KTH).

• CAPRES develops new technology for direct nano-
  and micro- scale electrical characterization of
  materials.

• Develops and sells products, based on centrifugal
  separation, for purification of processed air to
  several industrial applications.

18
Portfolio companies - Technology

• ScandiNova develops and sells solid state
  modulators (high power pulse generators) for
  applications such as radar systems, lasers,
  radiotherapy systems, research accelerators and
  X-ray systems.

• Diakrit is a supplier of architectural services
  in visualization and 3D modelling. Diakrit offers
  attractively packaged solutions to industries
  such as real estate and whitegoods manufacturers.

• Tail-f develops On-Device Management Software
  solutions for network equipment vendors, reducing
  development costs and speed time-to-market.

• ABBA musical in London, Toronto, USA and
  Australia etc. 16 shows globally

19
Portfolio companies - Life Science

• Digital X-ray imaging based on photon counting

• Technology for fetal monitoring during the final
  stage of delivery with focus on oxygen supply to
  the brain.

• Biotage AB is a leading supplier of complete
  solutions for Medical Chemistry Research and
  Applied genomic Analysis

20
Portfolio companies Life Science

• Develops extremely compact multi-parameter
  probes. The target group for these is
  international medical equipment companies working
  within the field of anaesthesia, intensive care
  and emergency care.

21
Portfolio companies Life Science

• A medtech company who has developed a
  non-pharmaceutical aid eliminating the allergen
  and particle exposure for patients with allergic
  asthma or rhinitis.

• Discovers and develops so called DIMS drugs
  (DIMS DNA-based Immunomodulary Sequence) for
  unmet medical needs in a variety of treatment
  areas such as inflammation and cancer. DIMS
  compounds contain oligonucleotides, which
  interact with Toll-like Receptors (TLR). Index
  also markets an IBD diagnostic kit

22
Portfolio companies Life Science

• DiLab develops and markets instruments for
  automation of measurement analysis in early and
  preclinical in-vivo drug discovery.

• A Medtech company developing a new noninvasive
  accurate method for the diagnosis of malignant
  melanoma and other skin cancers.

• A Swedish medtech company which developes a new
  method to prevent brain damage by
  cooling of the brain.

23
Portfolio companies Baltic

• The first top class 18-hole golf course in
  Lithuania opened in Spring 2006.

• VDNET a leading provider of triple play
  services (cable tv, internet and IP telephony) in
  capital city Vilnius and Mariajampole, Lithuania

24
Portfolio companies UK

• ShoZu is the leading provider of mobile social
  media services that connect mobile consumers with
  their online social networks, personal blogs,
  photo storage sites and other Web 2.0 properties
  from the handset

• Nomad provides specialty mobile network solutions
  for the global transportation industry with a
  current focus on passenger trains.

25
Our success factors
Analysis

• Careful selection

Active ownership

• Skill and commitment

Growth in value

• Active measures to increase value and enable exits

26
Investment process
27
Please contact us

• SEB Venture Capital
• Stockholm
• Kungsträdgårdsgatan 8, 106 40 STOCKHOLM
• 46 8 763 79 00
• London
• Scandinavian House
• 2-6 Cannon Street, London EC4M6XX
• 44 20 7246 4000
• Vilnius
• Jogailos g. 10, LT-01116 Vilnius
• 370 5 268 2407
• venturecapital_at_seb.se
• http//www.seb.se/venturecapital